Upper Urinary Calculi
Conditions
Interventions
trial group:Zhuhai Pusen disposable, electronic, flexible ureteroscope
control group:German KARL STORZ fiberoptic flexible ureteroscope
Sponsors
The First Affiliated Hospital of Sun Yat-sen University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) aged 18~60 years male and female; (2) by color Doppler ultrasound, X-ray or CT examination, the upper ureteral calculi or renal calculi is =2cm ,or proved to have multiple stones in single kidney and the largest diameter was more than 2cm; (3) preoperative urinary tract infection has been controlled: stones with infection and fever should be treated with antibotics till a normal body temperature for at least 3 days; (4) organ function must meet the following requirements: Bone marrow: blood routine results showed that hemoglobin was more than 90g/L, platelets were more than 100x10^9/L, and the absolute count of neutrophils was more than 1.5x10^9/L; Liver: serum bilirubin is less than 1.5 times the upper limit of normal value, aspartate aminotransferase and alanine aminotransferase are less than 2.5 times the normal upper limit; Kidney: the upper limit of normal value of serum creatinine was less than 1.25 times; (5) for women with fertility, effective contraceptive measures are used for at least 1 months before screening, and the use of such measures during the whole period of the study is agreed; (6) the subjects indicated that they were willing to complete all the steps and the research intervention cycle in the study; (7) to provide a signed and dated informed consent.
Exclusion criteria
Exclusion criteria: (1) the affected side is associated with urinary malformations, such as ureteropelvic junction obstruction, ureteral stricture and so on; (2) pyelography or CT examination confirmed that the body of the stone was located in the renal calyx diverticulum; (3) pyelography or CT examination showed that the main body of the stone was located in the lower renal calyx and the angle of the renal pelvis was less than 30 degrees; (4) patients with renal insufficiency; (5) pregnancy or lactation; (6) lung function tests showed moderate or above lung function impairment in patients with severe lung disease, asthma or COPD history; (7) diagnosed as bleeding or hypercoagulability; (8) subjects were enrolled in another experimental instrument, drug or biological research; (9) any unstable or possible condition for the safety of the subjects and their compliance with the study, or the researchers believe that the subjects have any other factors that are not appropriate to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| video quality fine rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| lithotripsy success rate; | — |
Countries
China
Contacts
Public ContactWu Rongpei
The First Affiliated Hospital of Sun Yat-sen University
Outcome results
None listed